BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29497013)

  • 1. Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience.
    Mak CM; Chen SP; Mok NS; Siu WK; Lee HH; Ching CK; Tsui PT; Fong NC; Yuen YP; Poon WT; Law CY; Chong YK; Chan YW; Yung TC; Fan KY; Lam CW
    Hong Kong Med J; 2018 Aug; 24(4):340-349. PubMed ID: 29497013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.
    Jiménez-Jáimez J; Alcalde Martínez V; Jiménez Fernández M; Bermúdez Jiménez F; Rodríguez Vázquez Del Rey MDM; Perin F; Oyonarte Ramírez JM; López Fernández S; de la Torre I; García Orta R; González Molina M; Cabrerizo EM; Álvarez Abril B; Álvarez M; Macías Ruiz R; Correa C; Tercedor L
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):808-816. PubMed ID: 28566242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype-driven molecular autopsy for sudden cardiac death.
    Cann F; Corbett M; O'Sullivan D; Tennant S; Hailey H; Grieve JH; Broadhurst P; Rankin R; Dean JC
    Clin Genet; 2017 Jan; 91(1):22-29. PubMed ID: 27000522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The electrocardiographic abnormalities in highly trained athletes compared to the genetic study related to causes of unexpected sudden cardiac death.
    Macarie C; Stoian I; Dermengiu D; Barbarii L; Piser IT; Chioncel O; Carp A; Stoian I
    J Med Life; 2009; 2(4):361-72. PubMed ID: 20108749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized medicine: genetic diagnosis for inherited cardiomyopathies/channelopathies.
    Ackerman MJ; Marcou CA; Tester DJ
    Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):298-307. PubMed ID: 24775620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Yield of Genetic Testing in Young Athletes With T-Wave Inversion.
    Sheikh N; Papadakis M; Wilson M; Malhotra A; Adamuz C; Homfray T; Monserrat L; Behr ER; Sharma S
    Circulation; 2018 Sep; 138(12):1184-1194. PubMed ID: 29764897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
    Ackerman MJ; Priori SG; Willems S; Berul C; Brugada R; Calkins H; Camm AJ; Ellinor PT; Gollob M; Hamilton R; Hershberger RE; Judge DP; Le Marec H; McKenna WJ; Schulze-Bahr E; Semsarian C; Towbin JA; Watkins H; Wilde A; Wolpert C; Zipes DP
    Heart Rhythm; 2011 Aug; 8(8):1308-39. PubMed ID: 21787999
    [No Abstract]   [Full Text] [Related]  

  • 8. [Why do we need genetics in cardiac rhythmology?].
    Rieder M; Castiglione A; Asatryan B; Odening KE
    Herzschrittmacherther Elektrophysiol; 2020 Dec; 31(4):394-400. PubMed ID: 32661562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Qiu X; Liu W; Hu D; Zhu T; Li C; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Zhang L
    Am J Cardiol; 2009 May; 103(10):1439-44. PubMed ID: 19427443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.
    Tester DJ; Ackerman MJ
    Circulation; 2011 Mar; 123(9):1021-37. PubMed ID: 21382904
    [No Abstract]   [Full Text] [Related]  

  • 11. Channelopathies That Lead to Sudden Cardiac Death: Clinical and Genetic Aspects.
    Skinner JR; Winbo A; Abrams D; Vohra J; Wilde AA
    Heart Lung Circ; 2019 Jan; 28(1):22-30. PubMed ID: 30389366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies.
    Forleo C; D'Erchia AM; Sorrentino S; Manzari C; Chiara M; Iacoviello M; Guaricci AI; De Santis D; Musci RL; La Spada A; Marangelli V; Pesole G; Favale S
    PLoS One; 2017; 12(7):e0181842. PubMed ID: 28750076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac channelopathies in pediatric patients - 7-years single center experience.
    Illikova V; Hlivak P; Hatala R
    J Electrocardiol; 2015; 48(2):150-6. PubMed ID: 25554238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of variant reinterpretation in inherited cardiovascular diseases: Establishing the optimal timeframe.
    Fernandez-Falgueras A; Coll M; Iglesias A; Tiron C; Campuzano O; Brugada R
    PLoS One; 2024; 19(5):e0297914. PubMed ID: 38691546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote.
    Fujii Y; Matsumoto Y; Hayashi K; Ding WG; Tomita Y; Fukumoto D; Wada Y; Ichikawa M; Sonoda K; Ozawa J; Makiyama T; Ohno S; Yamagishi M; Matsuura H; Horie M; Itoh H
    J Cardiol; 2017 Jul; 70(1):74-79. PubMed ID: 27816319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.
    Ortiz-Genga MF; Cuenca S; Dal Ferro M; Zorio E; Salgado-Aranda R; Climent V; Padrón-Barthe L; Duro-Aguado I; Jiménez-Jáimez J; Hidalgo-Olivares VM; García-Campo E; Lanzillo C; Suárez-Mier MP; Yonath H; Marcos-Alonso S; Ochoa JP; Santomé JL; García-Giustiniani D; Rodríguez-Garrido JL; Domínguez F; Merlo M; Palomino J; Peña ML; Trujillo JP; Martín-Vila A; Stolfo D; Molina P; Lara-Pezzi E; Calvo-Iglesias FE; Nof E; Calò L; Barriales-Villa R; Gimeno-Blanes JR; Arad M; García-Pavía P; Monserrat L
    J Am Coll Cardiol; 2016 Dec; 68(22):2440-2451. PubMed ID: 27908349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
    Tester DJ; Arya P; Will M; Haglund CM; Farley AL; Makielski JC; Ackerman MJ
    Heart Rhythm; 2006 Jul; 3(7):800-5. PubMed ID: 16818210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from testing cardiac channelopathy and cardiomyopathy genes in individuals who died suddenly: A two-year prospective study in a large medical examiner's office with an in-house molecular genetics laboratory and genetic counseling services.
    Williams N; Manderski E; Stewart S; Bao R; Tang Y
    J Genet Couns; 2020 Apr; 29(2):293-302. PubMed ID: 31436011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies.
    Crotti L; Kotta MC
    Int J Cardiol; 2017 Jun; 237():45-48. PubMed ID: 28532586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.